X-Therma Inc., founded in 2014, is a groundbreaking player in the Biotechnology, Health Care, and Life Sciences industries. The company is spearheading advances with its innovative approach to address critical challenges in the storage of biological products. Leveraging convergent biomimetic nanotechnology, X-Therma Inc. aims to enhance biomanufacture processes and ensure the safe transport and long-term sustainability of crucial medical elements like advanced cell therapies, in vitro fertilization, and organ transplants.
The company's technology responds to the rapidly expanding field of regenerative medicine, boasting significant potential to transform how biological materials are preserved and utilized globally. Headquartered in the United States, it strategically positions itself within a lucrative and fast-growing market.
In its latest funding round dated 13 March 2024, X-Therma Inc. secured a $22.40M Series B investment, backed by notable investors such as LOREA AG and Starling Locke Capital, underscoring strong investor confidence and support.